放射線治療チーム、2019 ASTRO in Chicago で発表

2019年09月20日

915-18日、米国シカゴで米国放射線腫瘍学会 (ASTRO) が開催され、大西教授、前畠先生、斎藤()先生、野中先生の4名が発表しました。

 

大西洋 教授:
Prognosis after Local Recurrence or Metastases in Medically Operable Stage I Non-Small Cell Lung Cancer Patients Treated By Stereotactic Body Radiotherapy.

 

前畠良康 先生:
Stereotactic Body Radiotherapy for Lymph Node Oligometastases.

 

斎藤正英 先生:
Deep Inspiration Breath-Hold Irradiation for Left Side Breast Cancer Using a New Combination of Respiration Monitoring Device and Optical Body Surface Monitoring System.

 

野中穂高 先生:
Pretreatment Modified Glasgow Prognostic Score as an Independent Predictor of Clinical Outcome in Patients with Stage I Non-small Lung Cancer after Stereotactic Body Radiation Therapy.

Prognostic Value of Pretreatment Neutrophil-to-Lymphocyte Ratio in Patients with Stage I Non-Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy: An Analysis Focusing on Metastases.